These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of glucose-mediated LDL oxidation on the P388D1 macrophage-like cell line. Millican SA; Bagga M; Eddy R; Mitchinson MJ; Hunt JV Atherosclerosis; 1997 Feb; 129(1):17-25. PubMed ID: 9069512 [TBL] [Abstract][Full Text] [Related]
3. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Cushing SD; Berliner JA; Valente AJ; Territo MC; Navab M; Parhami F; Gerrity R; Schwartz CJ; Fogelman AM Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5134-8. PubMed ID: 1695010 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526 [TBL] [Abstract][Full Text] [Related]
5. LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress. Tsimikas S; Philis-Tsimikas A; Alexopoulos S; Sigari F; Lee C; Reaven PD Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):122-30. PubMed ID: 9888874 [TBL] [Abstract][Full Text] [Related]
6. Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus. Zoltowska M; Delvin E; Ziv E; Peretti N; Chartré M; Levy E Lipids; 2004 Jan; 39(1):81-5. PubMed ID: 15055239 [TBL] [Abstract][Full Text] [Related]
7. Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration. Achmad TH; Winterscheidt A; Lindemann C; Rao GS Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):153-9. PubMed ID: 9203162 [TBL] [Abstract][Full Text] [Related]
8. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057 [TBL] [Abstract][Full Text] [Related]
9. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Sakata N; Uesugi N; Takebayashi S; Nagai R; Jono T; Horiuchi S; Takeya M; Itabe H; Takano T; Myint T; Taniguchi N Cardiovasc Res; 2001 Feb; 49(2):466-75. PubMed ID: 11164857 [TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Han KH; Tangirala RK; Green SR; Quehenberger O Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1983-91. PubMed ID: 9848893 [TBL] [Abstract][Full Text] [Related]
11. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074 [TBL] [Abstract][Full Text] [Related]
12. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Kamanna VS; Pai R; Roh DD; Kirschenbaum MA Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611 [TBL] [Abstract][Full Text] [Related]
13. Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Desfaits AC; Serri O; Renier G Metabolism; 1997 Oct; 46(10):1150-6. PubMed ID: 9322798 [TBL] [Abstract][Full Text] [Related]
14. Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium. Renier G; Desfaits AC; Serri O Metabolism; 2000 Feb; 49(2 Suppl 1):17-22. PubMed ID: 10693915 [TBL] [Abstract][Full Text] [Related]
16. Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. Weber C; Draude G; Weber KS; Wübert J; Lorenz RL; Weber PC Atherosclerosis; 1999 Jul; 145(1):115-23. PubMed ID: 10428302 [TBL] [Abstract][Full Text] [Related]
17. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro. Wu CH; Lin JA; Hsieh WC; Yen GC J Agric Food Chem; 2009 Jun; 57(11):5058-64. PubMed ID: 19489629 [TBL] [Abstract][Full Text] [Related]
18. Is oxidized low density lipoprotein involved in the recruitment and retention of monocyte/macrophages in the artery wall during the initiation of atherosclerosis? Parthasarathy S; Quinn MT; Steinberg D Basic Life Sci; 1988; 49():375-80. PubMed ID: 3250496 [No Abstract] [Full Text] [Related]
19. Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells. Lyons TJ; Li W; Wojciechowski B; Wells-Knecht MC; Wells-Knecht KJ; Jenkins AJ Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1176-80. PubMed ID: 10752957 [TBL] [Abstract][Full Text] [Related]
20. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Kobayashi K; Watanabe J; Umeda F; Nawata H Endocr J; 1995 Aug; 42(4):461-5. PubMed ID: 8556051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]